Novo Nordisk’s obesity drug Wegovy was cleared by U.S. regulators to treat an increasingly common liver disease, MASH.

A draft of RFK Jr.'s much-awaited strategy for a healthier America softens rhetoric on agricultural chemicals and stresses ...